Frank Lichtenberg
Courtney C. Brown Professor of Business
Courtney C. Brown Professor of Business
Healthcare and Pharmaceutical Management Program
BA, University of Chicago, 1973; MA, University of Pennsylvania, 1976; PhD, 1982
Year joined: 1983
E-mail: frl1@columbia.edu
Journal articles
"The contribution of pharmaceutical innovation to longevity growth in Germany and France, 2001–2007"
PharmacoEconomics
(2012)
More | Download PDF
"Has Pharmaceutical Innovation Reduced Social Security Disability Growth?"
International Journal of the Economics of Business
(2011)
More | Download PDF
"Despite steep costs, payments for new cancer drugs make economic sense"
Nature Medicine
(2011)
More | Download PDF
"The quality of medical care, behavioral risk factors, and longevity growth"
International Journal of Health Care Finance and Economics
(2011)
More | View research
"What Are the Respective Roles of the Public and Private Sectors in Pharmaceutical Innovation?"
Health Affairs
(2011)
More
"Are Increasing 5-Year Survival Rates Evidence of Success Against Cancer? A Reexamination Using Data from the U.S. and Australia"
Forum for Health Economics & Policy
(2010)
More | Download PDF
"Pharmaceutical innovation and mortality in the United States, 1960–2000. A commentary on Schnittker and Karandinos"
Social Science and Medicine
(2010)
More
"Pharmaceutical Price Discrimination and Social Welfare"
Capitalism and Society
(2010)
More | Download PDF
"The effect of drug vintage on survival: Micro evidence from Puerto Rico's Medicaid program"
Advances in health economics and health services research
(2010)
More | Download PDF
"Availability of New Drugs and Americans' Ability to Work"
Journal of Occupational and Environmental Medicine
(2005)
More | Download PDF
"The Impact of New Drug Launches on Longevity: Evidence from Longitudinal, Disease-Level Data from 52 Countries, 1982-2001"
International Journal of Health Care Finance and Economics
(2005)
More | Download PDF
"The Effects of Medicare on Health Care Utilization and Outcomes"
Frontiers in Health Policy Research
(2002)
More | Download PDF
"Do (More and Better) Drugs Keep People Out of Hospitals?"
American Economic Review
(1996)
More | Download PDF
"The Private R and D Investment Response to Federal Design and Technical Competitions"
American Economic Review
(1988)
More | Download PDF
"The Comparative Advantage of Educated Workers in Implementing New Technology"
Review of Economics and Statistics
(1987)
More | Download PDF
Working papers
"The Impact of New (Orphan) Drug Approvals on Premature Mortality from Rare Diseases in the U.S. and France, 1999–2007"
Working Paper
(2011)
More | Download PDF
"Has medical innovation reduced cancer mortality?"
Working Paper No. 15880
(2010)
More | Download PDF
"Is Home Health Care a Substitute for Hospital Care?"
Working paper
(2010)
More | Download PDF
"The impact of medical knowledge accumulation and diffusion on health: Evidence from Medline and other N.I.H. data"
Working paper
(2010)
More | Download PDF
"The Quality of Medical Care, Behavioral Risk Factors, and Longevity Growth"
NBER Working Papers, Working Paper 15068
(2009)
More | Download PDF
"Benefits and Costs of Newer Drugs: An Update"
Working paper
(2005)
More | View research
"Pharmaceutical-Embodied Technical Progress, Longevity, and Quality of Life: Drugs as 'Equipment for Your Health'"
Working paper
(2005)
More | View research
"Sources of U.S. Longevity Increase, 1960-1997"
Working paper
(2005)
More | View research
"The Dual Effects of Intellectual Property Regulations: Within- and Between-Patent Competition in the U.S. Pharmaceuticals Industry"
Working paper
(2005)
More | View research
"The Effect of Changes in Drug Utilization on Labor Supply and Per Capita Output"
Working paper
(2005)
More | View research
"The Effect of Education on Medical Technology Adoption: Are the More Educated More Likely to Use New Drugs?"
Working paper
(2005)
More | View research
"The Expanding Pharmaceutical Arsenal in the War on Cancer"
NBR Working Paper 10328
(2005)
More | Download PDF
"The Impact of New Drug Launches on Longevity: From 52 Countries, 1982-2001"
Working paper
(2005)
More | Download PDF
"The Effect of New Drugs on Mortality from Rare Diseases and HIV"
NBER Working Paper 8677
(2002)
More | View research
"The Benefits and Costs of Newer Drugs: Evidence from the 1996 Medical Expenditure Panel Survey"
NBER Working Paper 8147
(2001)
More | View research
"Pharmaceutical Innovation, Mortality Reduction, and Economic Growth"
NBER Working Paper W6569
(1998)
More | View research
"The Allocation of Publicly-Funded Biomedical Research"
NBER Working Paper 6601
(1998)
More | View research
"The Effect of Pharmaceutical Utilization and Innovation on Hospitalization and Mortality"
NBER Working Paper No. W5418
(1996)
More | View research
Books
Corporate Takeovers and Productivity
(1992)
More
Chapters
"Pharmaceutical Knowledge-Capital Accumulation and Longevity"
Measuring Capital in the New Economy
(2005)
More | Download PDF
Web-only articles
"Importation and Innovation"
Chazen Web Journal of International Business
(2005)
More | Download PDF
"Pharmaceutical Innovation and the Burden of Disease in Developing and Developed Countries"
Chazen Web Journal of International Business
(2005)
More | Download PDF